United Therapeutics (NSDQ:UTHR) announced today that it launched its Remunity pump for Remodulin in patients with pulmonary arterial hypertension (PAH). Research Triangle Park, N.C.-based United Therapeutics’ Remunity pump initially received FDA clearance in May 2019 for patient filling, adding another 510(k) clearance in February 2020 to enable cassettes to be prefilled with Remodulin by contracted specialty […]
DEKA Research and Development Corp.
United Therapeutics and Deka Research and Development have received FDA 510(k) clearance for the co-developed RemUnity system. The RemUnity system is a subcutaneous delivery system for Remodulin injections. The two companies have co-developed the device that is indicated to treat pulmonary arterial hypertension. “We developed the RemUnity system to address safety and patient convenience problems […]
Mobius Bionics, the company commercializing the robotic LUKE arm developed by Dean Kamen’s DEKA research and development, said last week the 1st 2 LUKE prosthetic arms were provided to the US Dept. of Veterans Affairs. The LUKE arm is designed as a robotic prosthetic arm for patients with forearm through shoulder-level amputations, and allows for a […]
The robotic LUKE arm developed by Dean Kamen’s DEKA research and development company is looking to hit the market later this year, being commercialized by Mobius Bionics. The LUKE arm is designed as a robotic prosthetic arm for patients with forearm through shoulder-level amputations, and allows for a range of different motion, including overhead, behind […]
Toyota Motor North America said last week that it’s planning to resurrect the iBot stair-climbing wheelchair developed by famed investor Dean Kamen’s DEKA Research & Development company. The deal calls for DEKA to complete the development and launch of a new version of the iBot, the Japanese auto maker said. Toyota said it will also license the […]
The U.S. Defense Dept. awarded a 57-month contract worth nearly $7 million to Dean Kamen’s Deka Innovative Solutions for the sensorized prosthetic arm Deka developed. The Deka arm is the 1st prosthetic arm to translate muscle signals into action that’s approved for the U.S. market. The device won de novo approval from the FDA in May […]
The FDA today said it will allow the 1st prosthetic arm to translate muscle signals into action onto the U.S. market under its de novo protocol for innovative devices. The prosthesis, called the DEKA arm system, was developed by inventor Dean Kamen’s DEKA Integrated Solutions.
Dean Kamen is perhaps most commonly known for having invented the Segway, but he’s also invented a prosthetic robotic arm, a portable dialysis system and a robotic wheelchair that can climb stairs.
Baxter International Inc. (NYSE:BAX) notched a pair of wins over the past 24 hours, acquiring Archemix Corp.’s hemophilia assets and winning an investigational device exemption for a home hemodialysis system from the Food & Drug Administration.